Author:
Zuckier L. S.,Freeman L. M.
Publisher
Springer Berlin Heidelberg
Reference120 articles.
1. Ahmad M, Witztum KF, Fletcher JW, Hendershott LR, Klos D, George EA, Donati RM (1977) Xenon-133 accumulation in hepatic steatosis. J Nucl Med 18:881–885
2. Alderson PO, Adams DF, McNeil BJ, Sanders R, Siegelman SS, Finberg HJ, Hessel SJ, Abrams HL (1983) Computed tomography, ultrasound, and scintigraphy of the liver in patients with colon or breast carcinoma: a prospective comparison. Radiology 149:225–230
3. Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H (2003) FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med 28:192–197
4. Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D (2004) Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8:90–97
5. Armas RR (1985) Clinical studies with spleen-specific radiolabeled agents. Semin Nucl Med 15:260–275